Notice Information
Notice Title
Malaria & Arbovirus detection assays
Notice Description
The Kit Evaluation Group (KEG) assesses the suitability of molecular and serological microbiological assays to be used for the screening of blood and non-blood (e.g. stem cell, tissue) donors to ensure assays are suitable in terms of sensitivity and specificity. KEG approval of suitable assays is a requirement of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).<br/><br/>NHSBT are looking to perform two evaluations, one on malaria detection assays and the other on arbovirus detection assays, which utilise high-throughput automated Nucleic Acid Testing (NAT) technology. This system needs to be integrated (extraction and amplification stages on the same automated equipment) and target DNA or RNA in blood samples collected from blood and non-blood donors. An automated and integrated NAT system is essential to minimise manual steps and to allow for high-throughput testing.<br/><br/>These evaluations are driven by horizon scanning and testing resilience and the proposed work would be standalone evaluations not linked to any procurement exercises. To learn more about KEG we will be holding virtual webinars in the summer of 2024.
Lot Information
Lot 1
The Kit Evaluation Group (KEG) assesses the suitability of molecular and serological microbiological assays to be used for the screening of blood and non-blood (e.g. stem cell, tissue) donors to ensure assays are suitable in terms of sensitivity and specificity. Kit Evaluation Group (KEG) approval of suitable assays is a requirement of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).
NHSBT are looking to perform two evaluations, one on malaria detection assays and the other on arbovirus detection assays, which utilise high-throughput automated Nucleic Acid Testing (NAT) technology. This system needs to be integrated (extraction and amplification stages on the same automated equipment) and target DNA or RNA in blood samples collected from blood and non-blood donors. An automated and integrated NAT system is essential to minimise manual steps and to allow for high-throughput testing.
These evaluations are driven by horizon scanning and testing resilience and the proposed work would be standalone evaluations not linked to any procurement exercises. To learn more about KEG we will be holding virtual webinars in the summer of 2024.
Please email tennille.madigan@nhsbt.nhs.uk for further information and expressions of interest by 30th April 2024.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-044445
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/006506-2024
- Current Stage
- Planning
- All Stages
- Planning
Procurement Classification
- Notice Type
- Planning Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Not Specified
- Procurement Method Details
- Not specified
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
71 - Architectural, construction, engineering and inspection services
-
- CPV Codes
33124130 - Diagnostic supplies
33141625 - Diagnostic kits
33696200 - Blood-testing reagents
71900000 - Laboratory services
Notice Value(s)
- Tender Value
- £1
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 29 Feb 20241 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- 30 Jun 2024Expired
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Planned
- Lots Status
- Planned
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS BLOOD AND TRANSPLANT
- Contact Name
- Tennille Madigan
- Contact Email
- tennille.madigan@nhsbt.nhs.uk
- Contact Phone
- +44 7795483583
Buyer Location
- Locality
- BRISTOL
- Postcode
- BS16 7FG
- Post Town
- Bristol
- Country
- England
-
- Major Region (ITL 1)
- TLK South West (England)
- Basic Region (ITL 2)
- TLK5 West of England
- Small Region (ITL 3)
- TLK52 Bath & North East Somerset and South Gloucestershire
- Delivery Location
- TLK12 Bath and North East Somerset, North Somerset and South Gloucestershire
-
- Local Authority
- South Gloucestershire
- Electoral Ward
- Emersons Green
- Westminster Constituency
- Filton and Bradley Stoke
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-044445-2024-02-29T11:52:51Z",
"date": "2024-02-29T11:52:51Z",
"ocid": "ocds-h6vhtk-044445",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-044445",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Malaria & Arbovirus detection assays",
"status": "planned",
"classification": {
"scheme": "CPV",
"id": "71900000",
"description": "Laboratory services"
},
"mainProcurementCategory": "services",
"description": "The Kit Evaluation Group (KEG) assesses the suitability of molecular and serological microbiological assays to be used for the screening of blood and non-blood (e.g. stem cell, tissue) donors to ensure assays are suitable in terms of sensitivity and specificity. KEG approval of suitable assays is a requirement of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).<br/><br/>NHSBT are looking to perform two evaluations, one on malaria detection assays and the other on arbovirus detection assays, which utilise high-throughput automated Nucleic Acid Testing (NAT) technology. This system needs to be integrated (extraction and amplification stages on the same automated equipment) and target DNA or RNA in blood samples collected from blood and non-blood donors. An automated and integrated NAT system is essential to minimise manual steps and to allow for high-throughput testing.<br/><br/>These evaluations are driven by horizon scanning and testing resilience and the proposed work would be standalone evaluations not linked to any procurement exercises. To learn more about KEG we will be holding virtual webinars in the summer of 2024.",
"value": {
"amount": 1,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"description": "The Kit Evaluation Group (KEG) assesses the suitability of molecular and serological microbiological assays to be used for the screening of blood and non-blood (e.g. stem cell, tissue) donors to ensure assays are suitable in terms of sensitivity and specificity. Kit Evaluation Group (KEG) approval of suitable assays is a requirement of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).<br/><br/>NHSBT are looking to perform two evaluations, one on malaria detection assays and the other on arbovirus detection assays, which utilise high-throughput automated Nucleic Acid Testing (NAT) technology. This system needs to be integrated (extraction and amplification stages on the same automated equipment) and target DNA or RNA in blood samples collected from blood and non-blood donors. An automated and integrated NAT system is essential to minimise manual steps and to allow for high-throughput testing.<br/><br/>These evaluations are driven by horizon scanning and testing resilience and the proposed work would be standalone evaluations not linked to any procurement exercises. To learn more about KEG we will be holding virtual webinars in the summer of 2024. <br/>Please email tennille.madigan@nhsbt.nhs.uk for further information and expressions of interest by 30th April 2024.",
"status": "planned"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "71900000",
"description": "Laboratory services"
},
{
"scheme": "CPV",
"id": "33141625",
"description": "Diagnostic kits"
},
{
"scheme": "CPV",
"id": "33124130",
"description": "Diagnostic supplies"
},
{
"scheme": "CPV",
"id": "33696200",
"description": "Blood-testing reagents"
}
],
"deliveryAddresses": [
{
"region": "UKK12"
}
],
"deliveryLocation": {
"description": "NHS Blood and Transplant Site: Filton"
},
"relatedLot": "1"
}
],
"communication": {
"futureNoticeDate": "2024-07-01T00:00:00+01:00",
"atypicalToolUrl": "https://health-family.force.com/s/Welcome"
}
},
"parties": [
{
"id": "GB-FTS-13217",
"name": "NHS Blood and Transplant",
"identifier": {
"legalName": "NHS Blood and Transplant"
},
"address": {
"streetAddress": "203 Longmead Rd, Avon",
"locality": "Bristol",
"region": "UKK12",
"postalCode": "BS16 7FG",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Tennille Madigan",
"telephone": "+44 7795483583",
"email": "tennille.madigan@nhsbt.nhs.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.nhsbt.nhs.uk",
"buyerProfile": "https://www.nhsbt.nhs.uk",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
}
],
"buyer": {
"id": "GB-FTS-13217",
"name": "NHS Blood and Transplant"
},
"language": "en"
}